The Portrait of an Adult Liver Transplant Recipient in the United States From 1987 to 2013
Since the first liver transplant, tremendous advances in organ preservation, surgical techniques and postoperative management have occurred. These advances have made liver transplantation the standard of care for patients with end-stage liver disease. [1] [2] [3] In this study, we describe how the clinicodemographic portrait of adult liver transplant recipients has changed in the United States over the past 25 years. Results | A total of 108 707 adult liver transplants performed in 153 different transplant centers across the country were included (Table) . Consistent w ith the changes in the general US population, liver transplant recipients are becoming increasingly older. Nevertheless, the increase in the mean age (7.3 years between cycles 1 and 4) is greater than that for patients with the diagnosis of chronic liver disease (41.1-45.3 years for the same time period 4 ). In contrast, changes in the racial/ethnic profile of transplant recipients were similar to those seen in the US general population. 4 Also, the proportion of male transplant recipients increased over time (Table) . Furthermore, patients' clinical presentation and functional status suggest that transplant recipients are becoming sicker. In particular, the rates of nearly all chronic conditions increased, and the average model for end-stage liver disease (MELD) (currently used for prioritization of wait-listed candidates 3 ) score increased slightly. Of the indications for liver transplantation, the proportion of alcoholic liver disease decreased while that of primary liver cancer increased (Table) . Of chronic liver disease etiologies, hepatitis C virus (HCV), alcoholic liver disease, and nonalcoholic fatty liver disease are now the most prevalent, and while alcoholic liver disease decreased, nonalcoholic fatty liver disease has shown a rapid increase (Table) .
Discussion | The results of this descriptive study show how liver transplant recipients have changed over the past 2 decades. In particular, liver transplant recipients in the United States have become older, predominantly male and with more comorbidities. Although the reasons are not entirely clear, one major contributor to this change may be related to the easing of some listing criteria for liver transplant candidates, such as increasing the threshold for age and body mass index. In addition, the increase in age could be related to the aging of the "baby boomer" cohort with high prevalence of HCV, the most common indication for liver transplantation. The explanation for the observed sex disparity remains unclear. Although sex bias from MELD allocation has been reported, 5 it is also important to note that the 2 most common indications for liver transplantation, HCV and hepatocellular carcinoma, have male predominance. 6 Our results also suggest that liver transplant recipients are becoming sicker. This may reflect the mandated transition to the "sickest-first" approach by MELD allocation. 2, 3 We also noted an increase in the rates of comorbidities related to metabolic syndrome, which may be explained by the increasing prevalence of obesity and its complications in the United States. However, a steady rather than abrupt increase in the rates of most of comorbidities (Figure) could
Variation in Inpatient Costs of Hematopoietic Cell Transplantation Among Transplant Centers in the United States
Hematopoietic cell transplantation (HCT) using the patient's own (autologous) or a donor's (allogeneic) HCT progenitor cells is a highly effective but costly therapy for life-threatening blood disorders and cancers. Despite the small number of annual procedures (20 000 a year in the United States), HCT hospitalization spending increased from $684 million to $1. 
